Waters Corporation (WAT) Position Raised by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC boosted its stake in Waters Corporation (NYSE:WAT) by 3.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,745 shares of the medical instruments supplier’s stock after purchasing an additional 310 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Waters Corporation were worth $1,792,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently made changes to their positions in the company. Oppenheimer Asset Management Inc. raised its stake in Waters Corporation by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after purchasing an additional 2 shares in the last quarter. Watermark Asset Management Inc. purchased a new stake in Waters Corporation in the first quarter valued at approximately $106,000. First Manhattan Co. purchased a new stake in Waters Corporation in the second quarter valued at approximately $130,000. Edmond DE Rothschild Holding S.A. purchased a new stake in Waters Corporation in the second quarter valued at approximately $160,000. Finally, Acrospire Investment Management LLC raised its stake in Waters Corporation by 117.4% in the second quarter. Acrospire Investment Management LLC now owns 926 shares of the medical instruments supplier’s stock valued at $170,000 after purchasing an additional 500 shares in the last quarter. 91.00% of the stock is currently owned by institutional investors and hedge funds.
In other Waters Corporation news, SVP Rohit Khanna sold 18,400 shares of the stock in a transaction on Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the sale, the senior vice president now owns 22,477 shares in the company, valued at $4,175,777.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Christopher A. Kuebler sold 3,500 shares of the stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the completion of the sale, the director now owns 17,849 shares in the company, valued at approximately $3,206,929.83. The disclosure for this sale can be found here. Corporate insiders own 5.07% of the company’s stock.
Waters Corporation (NYSE WAT) opened at 183.83 on Thursday. Waters Corporation has a one year low of $133.35 and a one year high of $190.39. The stock has a 50 day moving average of $182.95 and a 200 day moving average of $176.09. The company has a market cap of $14.67 billion, a PE ratio of 27.71 and a beta of 0.81.
Waters Corporation (NYSE:WAT) last released its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The company had revenue of $558.30 million for the quarter, compared to analyst estimates of $553.22 million. During the same quarter in the prior year, the firm posted $1.58 EPS. Waters Corporation’s quarterly revenue was up 4.0% compared to the same quarter last year. On average, analysts anticipate that Waters Corporation will post $7.39 earnings per share for the current fiscal year.
A number of equities research analysts recently weighed in on WAT shares. Jefferies Group LLC reaffirmed a “hold” rating and issued a $175.00 target price on shares of Waters Corporation in a research note on Thursday, August 31st. BidaskClub downgraded shares of Waters Corporation from a “strong-buy” rating to a “buy” rating in a research note on Friday, July 28th. Zacks Investment Research downgraded shares of Waters Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Bank of America Corporation reaffirmed a “neutral” rating and issued a $192.00 target price (up from $180.00) on shares of Waters Corporation in a research note on Friday, July 21st. Finally, Morgan Stanley reaffirmed an “underweight” rating and issued a $183.00 target price (up from $174.00) on shares of Waters Corporation in a research note on Wednesday, July 26th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $185.50.
ILLEGAL ACTIVITY WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/waters-corporation-wat-position-raised-by-mutual-of-america-capital-management-llc/1609506.html.
Waters Corporation Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.